Altuviiio Kit
Product Images NDC 71104-979

53 FDA label images from Bioverativ Therapeutics Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Altuviiio (NDC 71104-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bioverativ Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 01)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 01)
An instructional illustration showing hands peeling off a protective film or seal from a small, round container or vial, demonstrating a step in the use or preparation of the ALTUVIIIO KIT.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 02)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 02)
An instructional illustration showing hands attaching a spike component to a vial or container. The image labels the spike and demonstrates a downward motion to secure the connection, likely part of the preparation steps for using a drug kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 03)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 03)
Illustration showing hands removing a cap from a vial, demonstrating how to properly detach the vial cap for the ALTUVIIIO kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 04)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 04)
An instructional diagram showing hands attaching a circular disk to a syringe or injection device, illustrating a step in preparing or assembling the medication delivery system for ALTUVIIIO, a recombinant antihemophilic factor kit by Bioverativ Therapeutics Inc.*
FDA Label Image

Step 1 (01411972 Df40 4ccf 88f0 D3220e5abda9 05)

Step 1 (01411972 Df40 4ccf 88f0 D3220e5abda9 05)
An instructional illustration showing hands holding and examining the packaging of ALTUVIIIO, a human prescription drug kit. The top image shows the front or top side of the box with a label, and the bottom image shows the sides of the box, likely indicating how to inspect or read the packaging details before use.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 06)

FDA Label Image

Step 2 (01411972 Df40 4ccf 88f0 D3220e5abda9 07)

Step 2 (01411972 Df40 4ccf 88f0 D3220e5abda9 07)
Illustration diagram showing a vial adapter, a vial containing powdered medicine, a plunger rod, and a prefilled diluent syringe. These components are typically part of a kit for preparing a medication dose, including liquefying powdered medicine with a diluent for injection.*
FDA Label Image

Step 2 (01411972 Df40 4ccf 88f0 D3220e5abda9 08)

Step 2 (01411972 Df40 4ccf 88f0 D3220e5abda9 08)
An instructional illustration showing items not included in the ALTUVIIIO kit carton from Bioverativ Therapeutics Inc. The items are infusion set, tourniquet, alcohol wipes, cotton ball, and a container, each represented by simple line drawings with labels.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 09)

FDA Label Image

Step 3 (01411972 Df40 4ccf 88f0 D3220e5abda9 10)

Step 3 (01411972 Df40 4ccf 88f0 D3220e5abda9 10)
An instructional illustration showing a vial and a syringe with a plunger, accompanied by a thermometer icon indicating a temperature increase. The image appears to instruct warming the vial before use, relevant for medication preparation in a kit form.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 11)

FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 12)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 12)
ALTUVIIIO kit packaging label showing the product name ALTUVIIIO, the nonproprietary name Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, and the dosage form KIT. The label identifies Bioverativ Therapeutics Inc. as the labeler. The packaging includes colored geometric design elements and regulatory symbols on a white background.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 13)

FDA Label Image

Step 4 (01411972 Df40 4ccf 88f0 D3220e5abda9 14)

Step 4 (01411972 Df40 4ccf 88f0 D3220e5abda9 14)
An instructional illustration showing two steps for opening a vial. The first step depicts pressing down on the vial cap, indicated by motion lines. The second step shows the cap being lifted away from the vial. These steps demonstrate how to properly access the contents of the vial in a medication kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 15)

FDA Label Image

Step 5 (01411972 Df40 4ccf 88f0 D3220e5abda9 16)

Step 5 (01411972 Df40 4ccf 88f0 D3220e5abda9 16)
An instructional illustration depicting the removal of a protective seal or cover from a small circular container or vial, showing hands peeling it off with an upward arrow indicating the motion. This likely relates to preparation steps in using the ALTUVIIIO kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 17)

FDA Label Image

Step 6 (01411972 Df40 4ccf 88f0 D3220e5abda9 18)

Step 6 (01411972 Df40 4ccf 88f0 D3220e5abda9 18)
An instructional illustration showing a hand holding a spike component for a medical kit, with an inset close-up of the spike. The image demonstrates how to position and insert the spike into a container or vial, using arrows to indicate movement direction.*
FDA Label Image

Step 7 (01411972 Df40 4ccf 88f0 D3220e5abda9 19)

Step 7 (01411972 Df40 4ccf 88f0 D3220e5abda9 19)
Instructional illustration showing hands removing a cap from a vial, indicating the proper way to open the vial by pulling the cap upward. The image is likely part of usage instructions for the ALTUVIIIO kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl.*
FDA Label Image

Step 8 (01411972 Df40 4ccf 88f0 D3220e5abda9 20)

Step 8 (01411972 Df40 4ccf 88f0 D3220e5abda9 20)
An instructional illustration showing hands attaching a circular disk by twisting it onto a syringe-like device, likely as part of the preparation process for ALTUVIIIO kit components.*
FDA Label Image

Step 9 (01411972 Df40 4ccf 88f0 D3220e5abda9 21)

Step 9 (01411972 Df40 4ccf 88f0 D3220e5abda9 21)
An instructional illustration showing a hand holding a syringe-like device with a cap and a labeled ridged part at the top. It appears to demonstrate how to hold or prepare the device, likely part of the ALTUVIIIO kit by Bioverativ Therapeutics Inc.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 22)

FDA Label Image

Step 10 (01411972 Df40 4ccf 88f0 D3220e5abda9 23)

Step 10 (01411972 Df40 4ccf 88f0 D3220e5abda9 23)
An instructional illustration showing a hand removing the cap from a vial and another hand twisting off or lifting a cap from an accompanying container, indicating preparation steps for medication administration using the kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 24)

FDA Label Image

Step 11 (01411972 Df40 4ccf 88f0 D3220e5abda9 25)

Step 11 (01411972 Df40 4ccf 88f0 D3220e5abda9 25)
An instructional illustration showing a person twisting the cap off a vial using both hands, with a purple circular arrow indicating the twisting motion. This likely depicts part of the preparation process for the ALTUVIIIO kit.*
FDA Label Image

Step 12 (01411972 Df40 4ccf 88f0 D3220e5abda9 26)

Step 12 (01411972 Df40 4ccf 88f0 D3220e5abda9 26)
An instructional diagram shows hands preparing a syringe by inserting the plunger into a vial adapter, demonstrating the assembly step needed for reconstituting or withdrawing medication in the ALTUVIIIO kit.*
FDA Label Image

Step 13 (01411972 Df40 4ccf 88f0 D3220e5abda9 27)

Step 13 (01411972 Df40 4ccf 88f0 D3220e5abda9 27)
An instructional illustration showing a hand holding a vial and syringe, with arrows indicating a twisting motion to mix or prepare the medication. The image suggests how to properly agitate or mix the contents, relevant to using the ALTUVIIIO kit for medication preparation.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 28)

FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 29)

FDA Label Image

Step 14 (01411972 Df40 4ccf 88f0 D3220e5abda9 30)

Step 14 (01411972 Df40 4ccf 88f0 D3220e5abda9 30)
An instructional illustration showing hands operating a syringe attached to a vial. The left panel depicts holding the vial with one hand and inserting the syringe plunger with the other, indicated by a downward arrow. The right panel shows the syringe being pulled upward to draw liquid from the vial, indicated by an upward arrow.*
FDA Label Image

Step 15 (01411972 Df40 4ccf 88f0 D3220e5abda9 31)

Step 15 (01411972 Df40 4ccf 88f0 D3220e5abda9 31)
An instructional illustration showing hands manipulating a syringe and vial, indicating twisting or turning the vial cap. This image likely depicts a step in preparing or assembling the medication kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 32)

FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 33)

FDA Label Image

Step 16 (01411972 Df40 4ccf 88f0 D3220e5abda9 34)

Step 16 (01411972 Df40 4ccf 88f0 D3220e5abda9 34)
An instructional illustration showing hands assembling or preparing a syringe connected to tubing with a three-way stopcock valve, demonstrating how to attach or adjust components for intravenous administration or infusion setup.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 35)

FDA Label Image

Step 17 (01411972 Df40 4ccf 88f0 D3220e5abda9 36)

Step 17 (01411972 Df40 4ccf 88f0 D3220e5abda9 36)
An instructional illustration showing a person preparing to inject a substance into the inner arm near the elbow, with a tourniquet applied above the injection site. The image depicts proper hand positioning and injection technique for administering an injection.*
FDA Label Image

Step 18 (01411972 Df40 4ccf 88f0 D3220e5abda9 37)

Step 18 (01411972 Df40 4ccf 88f0 D3220e5abda9 37)
An instructional illustration showing a pair of hands preparing a syringe. One hand holds the syringe with a vial attached, while the other hand pulls the plunger back, indicated by a purple upward arrow. The image likely demonstrates drawing medication into the syringe.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 38)

FDA Label Image

Step 19 (01411972 Df40 4ccf 88f0 D3220e5abda9 39)

Step 19 (01411972 Df40 4ccf 88f0 D3220e5abda9 39)
An instructional illustration showing a person administering an injection in the arm with a blue tourniquet tied above the injection site and the needle inserted into a vein. The image depicts the process of intravenous infusion likely related to the drug ALTUVIIIO kit.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 40)

FDA Label Image

Step 20 (01411972 Df40 4ccf 88f0 D3220e5abda9 41)

Step 20 (01411972 Df40 4ccf 88f0 D3220e5abda9 41)
An instructional diagram showing an arm with tape securing plastic wings of an intravenous catheter or similar device. A hand is depicted removing or adjusting the tape from the skin near the insertion site.*
FDA Label Image

Step 21 (01411972 Df40 4ccf 88f0 D3220e5abda9 42)

Step 21 (01411972 Df40 4ccf 88f0 D3220e5abda9 42)
An instructional illustration showing a person's arm with an intravenous (IV) catheter inserted. A hand is holding a syringe connected to the IV line, with an arrow indicating the direction to push the syringe plunger. This image demonstrates the method for administering medication or fluids through an IV line.*
FDA Label Image

Step 22 (01411972 Df40 4ccf 88f0 D3220e5abda9 43)

Step 22 (01411972 Df40 4ccf 88f0 D3220e5abda9 43)
An instructional illustration showing a person cleaning or wiping the inner elbow area of their arm with a cotton ball or pad, likely demonstrating preparation for an injection or medical procedure.*
FDA Label Image

Step 23 (01411972 Df40 4ccf 88f0 D3220e5abda9 44)

Step 23 (01411972 Df40 4ccf 88f0 D3220e5abda9 44)
Illustration showing a hand holding a medical syringe with a connected vial, positioned above a red sharps disposal container. The image depicts the proper disposal process of injectable medical waste.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 45)

FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 46)

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 46)
ALTUVIIIO kit carton displaying the proprietary name and nonproprietary name Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. The label shows this is a human prescription drug by Bioverativ Therapeutics Inc. The carton features a simple design with text and a blue icon in the lower left corner.*
FDA Label Image

Image (01411972 Df40 4ccf 88f0 D3220e5abda9 47)

FDA Label Image

Principal Display Panel (250 IU Kit Carton)

Principal Display Panel (250 IU Kit Carton)
Packaging label for ALTUVIIIO 250 IU Nominal kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl for intravenous use. The label shows the product name, dosage strength, and includes multiple instruction panels. It features the Sanofi and Bioverativ Therapeutics Inc. logos, with additional details like NDC 71104-978-01 and a QR code for more information.*
FDA Label Image

Principal Display Panel (500 IU Kit Carton)

Principal Display Panel (500 IU Kit Carton)
Packaging label for ALTUVIIIO 500 IU Kit by Bioverativ Therapeutics Inc. The label includes the product name, generic name Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, NDC 71104-979-01, and instructions indicating it is for intravenous use. The label also features Sanofi branding, a QR code for more information, and package contents including lyophilized powder and prefilled syringe components.*
FDA Label Image

Principal Display Panel (1000 IU Kit Carton)

Principal Display Panel (1000 IU Kit Carton)
Packaging label for ALTUVIIIO, Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, 1000 IU Nominal strength. The label indicates it is for intravenous use and includes a NDC number 71104-981-01. Manufactured by Bioverativ Therapeutics Inc., the kit contains a single-dose vial, prefilled diluent syringe, sterile vial adapter, and package insert. The label features a QR code, Sanofi branding, and detailed product and storage information.*
FDA Label Image

Principal Display Panel (2000 IU Kit Carton)

Principal Display Panel (2000 IU Kit Carton)
Packaging label for ALTUVIIIO 2000 IU Nominal, a kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl for intravenous use. The label includes the NDC 71104-982-01 and is manufactured by Bioverativ Therapeutics Inc., a Sanofi company. The kit contains a single-dose vial, a prefilled syringe with sterile water, a vial adapter reconstitution device, and a package insert.*
FDA Label Image

Principal Display Panel (3000 IU Kit Carton)

Principal Display Panel (3000 IU Kit Carton)
Packaging label for ALTUVIIIO 3000 IU Nominal kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl for intravenous use. The label includes the NDC 71104-983-01, manufacturer Bioverativ Therapeutics Inc. (a Sanofi company), barcode, QR code for more information, and details about the kit contents including a single-dose vial with lyophilized powder, a prefilled diluent syringe, vial adapter device, and package insert.*
FDA Label Image

Principal Display Panel (4000 IU Kit Carton)

Principal Display Panel (4000 IU Kit Carton)
Packaging label for ALTUVIIIO 4000 IU Nominal kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, for intravenous use. The label includes manufacturer Bioverativ Therapeutics Inc. branding and Sanofi logo, with information about kit contents including single-dose vial with lyophilized powder, prefilled diluent syringe, vial adapter, and package insert. It also features a QR code linking to the product website and dosing and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.